ArticleJMIR research protocols2016

EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.

Angela E Rankine-Mullings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.